#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury Stress cardiomyopathy Methylmalonic acidaemia Squamous cell carcinoma of head and neck Heart disease congenital Congenital cystic kidney disease Vitamin B12 deficiency Loeys-Dietz syndrome Idiopathic pulmonary fibrosis Haemophagocytic lymphohistiocytosis Peripheral primitive neuroectodermal tumour of soft tissue Extra-osseous Ewing's sarcoma Allogenic stem cell transplantation Epidermolysis bullosa Metastatic gastric cancer More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Basic Information Rhabdomyosarcoma recurrent – Life with Disease Hairy cell leukaemia – Trials in Disease Pleural mesothelioma malignant – Basic Information Mantle cell lymphoma stage IV – Treatment Castleman’s disease – Treatment Haemophagocytic lymphohistiocytosis – Basic Information IgA nephropathy – Treatment Synovial sarcoma – Basic Information Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anitocabtagene Autoleucel Vinorelbine Tartrate Tumour Detection Dapagliflozin Propanediol Chlorphenamine Ramipril Adalimumab Phenazone Setmelanotide Vidofludimus Calcium Glasdegib Azd8205 Ecopipam Hydrochloride Ephedrine Hydrochloride Romosozumab Emavusertib Amantadine Hydrochloride AUROCELL-TX Mycophenolate Mofetil Dexketoprofen Trometamol More therapies…

    Learn about Your Condition

    Fungal infection CADASIL Leiomyosarcoma Medulloblastoma recurrent Growth hormone deficiency Dementia Herpes simplex reactivation Retinoblastoma Inflammatory bowel disease Hypocalcaemia Femoral neck fracture Skin neoplasm excision Pharyngeal cancer stage I Hypochondroplasia Lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • Lithium Carbonate
    France
  • Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +3
  • Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypothyroidism
    The Netherlands
  • Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Portal hypertension
    • Hepatic cirrhosis
    Investigated Drugs:
    • Norfloxacin
    Austria
  • Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Meningioma
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Octreotide Acetate
    • Bevacizumab
    Austria Denmark France Germany Italy The Netherlands +2
  • Study on [18F]Fluoro-PEG-Folate PET-CT Imaging to Monitor Therapy Response in Patients with Rheumatoid Arthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • [18F]Fluoro-Peg-Folate
    The Netherlands
Previous Page
1 … 303 304 305 306 307 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!